Say Chow - Haw ParLtd Group Finance Controller
| HAWPY Stock | USD 28.64 0.00 0.00% |
Executive
Mr. Chow Say Suan is Group Finance Controller of the Company. Mr Chow will oversee the nance function including nancial compliance and reporting, legal, secretarial compliance and governance practices. since 2019.
| Age | 45 |
| Tenure | 6 years |
| Phone | 65 6337 9102 |
| Web | https://www.hawpar.com |
Haw ParLtd Management Efficiency
Haw ParLtd's management efficiency ratios could be used to measure how well Haw ParLtd manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Betty Larson | Merck Company | 49 | |
| Mark Larkins | Johnson Johnson | N/A | |
| Susan Silbermann | Pfizer Inc | 63 | |
| Pierre Chancel | Sanofi ADR | 68 | |
| Catherine Adams | Bristol Myers Squibb | 54 | |
| Alan Hippe | Roche Holding Ltd | 56 | |
| Paivi Kerkola | Pfizer Inc | N/A | |
| Chirfi Guindo | Merck Company | 58 | |
| Duane Arsdale | Johnson Johnson | N/A | |
| Tracie Haas | AbbVie Inc | N/A | |
| Johannes Oosthuizen | Merck Company | 56 | |
| Elizabeth Forminard | Johnson Johnson | 53 | |
| David Redfern | GlaxoSmithKline PLC ADR | 58 | |
| Sandra Esq | Bristol Myers Squibb | 64 | |
| Samit MD | Bristol Myers Squibb | 56 | |
| Kimberly Jablonski | Bristol Myers Squibb | N/A | |
| Thomas MD | AbbVie Inc | 62 | |
| Cristina Wilbur | Roche Holding Ltd | 56 | |
| Jennifer JD | Merck Company | 47 | |
| Dalton III | Merck Company | 58 | |
| Peter Dannenbaum | Merck Company | N/A | |
Management Performance
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 |
Haw ParLtd Leadership Team
Elected by the shareholders, the Haw ParLtd's board of directors comprises two types of representatives: Haw ParLtd inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw ParLtd's management team and ensure that shareholders' interests are well served. Haw ParLtd's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw ParLtd's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd | ||
| Kun Chiew, Group Sec | ||
| Say Chow, Group Finance Controller | ||
| Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited | ||
| Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare | ||
| Tang Lee, Mang Communications | ||
| Tang Chow, Human Director | ||
| Brian Loo, Group Mang |
Haw Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw ParLtd a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 | |||
| Profit Margin | 0.79 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | (701.58 M) | |||
| Shares Outstanding | 55.34 M | |||
| Price To Earning | 21.33 X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 10.01 X | |||
| Revenue | 141.18 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Haw Pink Sheet Analysis
When running Haw ParLtd's price analysis, check to measure Haw ParLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw ParLtd is operating at the current time. Most of Haw ParLtd's value examination focuses on studying past and present price action to predict the probability of Haw ParLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw ParLtd's price. Additionally, you may evaluate how the addition of Haw ParLtd to your portfolios can decrease your overall portfolio volatility.